Nodus Oncology
Pre-clinicalExploiting genomic instability and replication stress to deliver significant advancements to cancer patients harbouring metabolic vulnerabilities.
Founded
2018
Focus
Small Molecules
About
Exploiting genomic instability and replication stress to deliver significant advancements to cancer patients harbouring metabolic vulnerabilities.
Funding History
1Total raised: $2.8M
Seed$2.8MUndisclosedSep 15, 2022
Company Info
TypePrivate
Founded2018
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile